Ignite Creation Date:
2024-05-05 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00462202
Status:
TERMINATED
Last Update Posted:
2017-03-03
First Post:
2007-04-16
Brief Title:
Open Label Tolerability and Safety Study of KRX-101 in Australia New Zealand and Hong Kong
Sponsor:
Keryx Biopharmaceuticals
Organization:
Keryx Biopharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-04
Start Date Type:
None
Primary Completion Date:
2008-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-04-16
First Submit QC Date:
April 17 2007
Study First Post Date:
2007-04-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2015-04-13
Disp First Submit QC Date:
April 13 2015
Disp First Post Date:
2015-05-05
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-03-02
Last Update Post Date:
2017-03-03
Last Update Post Date Type:
ACTUAL